Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN17186893
ISRCTN17186893
Completed
N/A

Evaluation of the adjuvant therapeutic efficacy of Bo-Er-Ning capsule (BENC) in advanced gastric cancer patients by a randomized clinical trial

Zhangqiu People's Hospital of Shandong0 sites120 target enrollmentMarch 24, 2018
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAdvanced gastric cancerCancerStomach, unspecified

Overview

Phase
N/A
Intervention
Not specified
Conditions
Advanced gastric cancer
Sponsor
Zhangqiu People's Hospital of Shandong
Enrollment
120
Status
Completed
Last Updated
7 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

2018 results in: https://www.ncbi.nlm.nih.gov/pubmed/30034946

Registry
who.int
Start Date
March 24, 2018
End Date
June 30, 2012
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Zhangqiu People's Hospital of Shandong

Eligibility Criteria

Inclusion Criteria

  • •1\. Age from 25 to 75 years
  • •2\. All patients were pathologically confirmed for stage IV or postoperative recurrence and metastasis GC
  • •3\. Karnofsky performance score (KPS) \= 80
  • •4\. No previous anticancer therapy
  • •5\. No dysfunction of heart, liver, lung and kidney

Exclusion Criteria

  • •1\. Age\<25 and \>75 years
  • •2\. Patients were not pathologically confirmed for stage IV or postoperative recurrence and metastasis GC
  • •3\. Karnofsky performance score (KPS) \< 80
  • •4\. Possess previous anticancer therapy
  • •5\. Possess dysfunction of heart, liver, lung and kidney

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
N/A
Russian observational program ODA
ISRCTN97780949JSC Servier3,032
Completed
N/A
Efficacy of patient-controlled paravertebral block for single intercostal video assisted thoracic surgeryPain in the postoperative periodSigns and Symptoms
ISRCTN24097424Second Affiliated Hospital of Zhejiang University260
Completed
N/A
Treating pulmonary fibrosis with co-trimoxazole
ISRCTN17464641orfolk and Norwich University Hospital NHS Trust342
Completed
Phase 1
Efficacy and safety of olaparib in relapsed and refractory chronic lymphocytic leukaemia patients with an 11q deletion or ATM mutation and relapsed/refractory patients with T-prolymphocytic leukaemia and mantle cell lymphomaChronic lymphocytic leukaemiaCancerLymphoid leukaemia
ISRCTN34386131niversity of Birmingham (UK)15
Completed
Phase 3
A phase III, randomised, controlled trial for the treatment of HIV-associated cryptococcal meningitis: oral fluconazole plus flucytosine or one week amphotericin B-based therapy vs two weeks amphotericin B-based therapy
ISRCTN45035509St George's University of London (UK)680